Home
Commodore Capital reported a 4.6% stake in Celldex Therapeutics CLDX · 3,028,335 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.6%
- Last report
- 5% · filed 25/04/10
- Shares held
- 3,028,335 sh
- Class
- Common Stock, par value $.001
- Holder
- Commodore Capital
- Event date
- 25/09/30
- Filed
- 25/11/14
4.6% stake · below 5%
- Stake
- 4.6%
- Last report
- 5%
- Since last report
- −0.4pp
Celldex Therapeutics trades, last 26 weeks
What else happened in Celldex Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Commodore Capital's other 5% stake reports
- Commodore Capital
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.2% stake
400,000 sh
5.2% stake
Filed 09/02
- Commodore Capital
5% stakeInflaRx
5% stakeInflaRx
IFRX
5.1% stake
7,475,000 sh
5.1% stake
Filed 08/17
- Commodore Capital
5% stakePalisade Bio
5% stakePalisade Bio
PALI
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeJatt II Acquisition
5% stakeJatt II Acquisition
JATT
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeRelay Therapeutics
5% stakeRelay Therapeutics
RLAY
5.5% stake
12,000,000 sh
5.5% stake
Filed 08/14
